Protecting Your Clients Against Off-Label Ozempic
International Drug Sourcing: Examining the Risks and Potential Rewards
Biosimilars, GLP-1s, and Stop-loss: Topics Benefit Advisors Need to Consider in Q3 2023
Everything you need to know about 340B in 2023
After 20 Years of Humira Prescriptions, Therapeutic Interchange Programs Give Employers Much-Needed Options
The 5 Most Expensive Gene Therapies in the U.S.
Three Key Times to Evaluate a Pharmacy Benefits Plan
What’s the Difference Between Manufacturer Coupons and Patient Assistance?
Enjoy our latest blogs, white papers and news by signing up for our newsletter today!
